Literature DB >> 22815375

Impact of coronary atherosclerosis on the efficacy of radiofrequency catheter ablation for atrial fibrillation.

Dennis W den Uijl1, Mark J Boogers, Marieke Compier, Serge A Trines, Arthur J H A Scholte, Katja Zeppenfeld, Martin J Schalij, Jeroen J Bax, Victoria Delgado.   

Abstract

AIMS: Coronary atherosclerosis has been associated with the development of atrial fibrillation (AF). However, little is known about the impact of coronary atherosclerosis on the outcome treatment of AF. The aim of this study was to investigate the impact of coronary atherosclerosis on the efficacy of radiofrequency catheter ablation (RFCA) for AF using multi-detector row computed tomography (MDCT).
METHODS: In 125 consecutive patients undergoing RFCA for AF, a pre-procedural MDCT examination (coronary angiography and/or coronary calcium score) was performed to evaluate the presence and severity of coronary atherosclerosis. Furthermore, all patients underwent a comprehensive echocardiographic evaluation to measure the left atrial size and to rule out structural heart disease. After RFCA all patients were regularly evaluated at the outpatient clinic.
RESULTS: After a mean follow-up of 12 ± 3 months, 78 patients (62%) had maintained stable sinus rhythm and 47 patients (38%) had recurrence of AF. Left atrial volume index was a significant predictor of AF recurrence after RFCA. The presence of coronary atherosclerosis on MDCT did not influence the efficacy of RFCA for AF.
CONCLUSIONS: The presence of coronary atherosclerosis on MDCT is not associated with a higher risk for AF recurrence after RFCA.

Entities:  

Mesh:

Year:  2012        PMID: 22815375     DOI: 10.1093/ehjci/jes144

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  2 in total

1.  Asymptomatic left circumflex artery stenosis is associated with higher arrhythmia recurrence after persistent atrial fibrillation ablation.

Authors:  Rodrigue Garcia; Mathilde Clouard; Fabian Plank; Bruno Degand; Séverine Philibert; Gabriel Laurent; Pierre Poupin; Saliman Sakhy; Matthieu Gras; Markus Stühlinger; Nándor Szegedi; Szilvia Herczeg; Judit Simon; Harry J G M Crijns; Eloi Marijon; Luc Christiaens; Charles Guenancia
Journal:  Front Cardiovasc Med       Date:  2022-09-26

2.  Prevalence of atrial fibrillation dependent on coronary artery status: Insights from the LIFE-Heart Study.

Authors:  Jelena Kornej; Sylvia Henger; Timm Seewöster; Andrej Teren; Ralph Burkhardt; Holger Thiele; Joachim Thiery; Markus Scholz
Journal:  Clin Cardiol       Date:  2020-10-27       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.